# A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis

> **NCT02583022** · PHASE2 · COMPLETED · sponsor: **Amorepacific Corporation** · enrollment: 74 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** PAC-14028 cream 1.0%
- **DRUG:** PAC-14028 cream vehicle
- **DRUG:** Elidel cream 1%

## Key facts

- **NCT ID:** NCT02583022
- **Lead sponsor:** Amorepacific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-01
- **Final completion:** 2015-08
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02583022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02583022, "A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02583022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*